Want to join the conversation?
$FSLR's gross margin for 3Q15 rose to 38.1% from 21.3% in the previous year quarter. The increase was primarily the result of a mix of higher gross profit systems projects sold and under construction during the period and a reduction in its module collection and recycling obligation.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.